— Know what they know.
Not Investment Advice
Also trades as: HLN.L (LSE) · $vol 126M · HLNCF (OTC) · $vol 0M

HLN NYSE

Haleon plc
1W: +0.6% 1M: +10.2% 3M: -0.7% YTD: +2.0% 1Y: +8.9% 3Y: +28.6%
$10.08
-0.12 (-1.18%)
After Hours: $10.18 (+0.10, +0.94%)
Weekly Expected Move ±3.8%
$9 $10 $10 $11 $11
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 72 · $44.9B mcap · 4.42B float · 0.305% daily turnover · Short 49% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 19.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.16 (down 98%), Haleon plc would be worth roughly what it owes.
Total debt $10.95B against a stock market value of $44.86B.
Distance to default 10.07 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $6.70B (short-term plus half of long-term), stock volatility 23.4%; Altman Z'' 3.98. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Cash Flow Trends

Operating Cash Flow
$2.3B -0.7% ▼
5Y CAGR: +10.2%
Capital Expenditures
$315M -26.0% ▼
5Y CAGR: -0.2%
Free Cash Flow
$2.0B -3.9% ▼
5Y CAGR: +12.6%
Dividends Paid
$599M -5.0% ▼
Buybacks
$640M -428.7% ▼
Net Change in Cash
-$770M -163.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$1.4B$1.1B$1.0B$1.4B$1.6B
Depreciation & Amort.$268M$287M$309M$324M$352M
Stock-Based Comp.$59M$78M$88M$102M$0
Change in Working Capital-$152M$181M-$219M$48M$250M
Other Non-Cash Items-$406M$336M$711M$385M$53M
Operating Cash Flow$1.4B$2.1B$2.1B$2.3B$2.3B
— Investing Activities —
Capital Expenditures-$298M-$328M-$234M-$250M-$404M
Acquisitions (Net)$112M$9.2B-$71M$0-$157M
Investment Purchases-$112M-$9.2B$0$0-$6M
Investment Sales$100M$700M$0$0$0
Other Investing$165M-$9.2B$171M$778M$0
Investing Cash Flow-$33M-$8.8B-$134M$528M-$567M
— Financing Activities —
Net Debt Issuance$8M$9.5B-$553M$592M-$1.3B
Stock Repurchased$0$0-$38M-$121M-$640M
Dividends Paid-$1.1B-$2.7B-$388M-$570M-$599M
Other Financing-$96M$107M-$589M-$1.4B-$39M
Financing Cash Flow-$1.2B$6.9B-$1.6B-$1.5B-$2.6B
Net Change in Cash$82M$205M$383M$1.2B-$770M
Cash End of Period$405M$611M$994M$2.2B$1.3B
Free Cash Flow$1.1B$1.7B$1.8B$2.1B$2.0B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms